Clinical Trials - In Follow-up

The clinical trials listed in this section are no longer recruiting new patients and some patients may still be receiving treatment. These trials are still monitoring their patients, collecting information and analysing the results with the aim of achieving the study’s objectives. Members can review the Trial Report in the Members Area.

Filter AGITG trials by

GIST

ALT GIST

The aim of ALT GIST is to determine whether an alternating treatment approach - using Imatinib and Regorafenib - improves disease control in patients with advanced (metastatic) gastrointestinal stromal tumours. Read More

Rare Cancers

Colorectal Cancer

A LA CART

NSW | QLD | VIC | Australia | New Zealand

The primary aim of the A La CaRT study is to determine whether laparoscopic-assisted resection is not inferior (or equivalent) to open rectal resection as a safe, effective oncologic approach to rectal cancer. Read More

Adjuvant/Neoadjuvant

Anal Cancer

InterAACT

The aim of InterAACT is to compare two different chemotherapy regimens for the treatment of inoperable locally advanced or metastatic anal cancer to demonstrate which is more effective and less toxic for patients with this disease. Read More

Rare Cancers

Oesophageal Cancer

DOCTOR

The DOCTOR study aims to compare the effectiveness of pre-operative treatment with cisplatin, 5 fluorouracil and docetaxel, with or without radiotherapy, in treating people who have shown a poor early response to standard chemotherapy for adenocarcinoma of the oesophagus and/or gastroesophageal junction.  Read More

Adjuvant/Neoadjuvant

NeuroEndocrine Tumours (NETs)

CONTROL NETS

NSW | QLD | VIC | WA

The aim of the CONTROL NETS trial is to find the optimal treatment to improve disease control in patients with advanced Neuroendocrine tumours (NETs). Read More

Rare Cancers